Bioceltix S.A.

WSE:BCX Rapporto sulle azioni

Cap. di mercato: zł373.3m

Bioceltix Crescita futura

Future criteri di controllo 0/6

Bioceltix is forecast to grow earnings and revenue by 26.3% and 149% per annum respectively while EPS is expected to grow by 33.7% per annum.

Informazioni chiave

26.3%

Tasso di crescita degli utili

33.7%

Tasso di crescita dell'EPS

Biotechs crescita degli utili36.4%
Tasso di crescita dei ricavi149.0%
Rendimento futuro del capitale proprion/a
Copertura analitica

Low

Ultimo aggiornamento07 Aug 2024

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

Jun 15
We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

Will Bioceltix (WSE:BCX) Spend Its Cash Wisely?

Jan 19
Will Bioceltix (WSE:BCX) Spend Its Cash Wisely?

We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

Sep 21
We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

May 09
We're Keeping An Eye On Bioceltix's (WSE:BCX) Cash Burn Rate

Previsioni di crescita degli utili e dei ricavi

WSE:BCX - Stime future degli analisti e dati finanziari passati (PLN Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/202613-9N/A-21
12/31/2025N/A-9N/A31
12/31/2024N/A-16N/A-141
6/30/2024N/A-16-14-14N/A
3/31/2024N/A-15-14-13N/A
12/31/2023N/A-14-15-15N/A
9/30/2023N/A-13-13-12N/A
6/30/2023N/A-12-13-12N/A
3/31/2023N/A-10-11-10N/A
12/31/2022N/A-9-8-8N/A
9/30/2022N/A-8-6-6N/A
3/31/2022N/A-5-4-4N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: BCX is forecast to remain unprofitable over the next 3 years.

Guadagni vs Mercato: BCX is forecast to remain unprofitable over the next 3 years.

Guadagni ad alta crescita: BCX is forecast to remain unprofitable over the next 3 years.

Ricavi vs Mercato: BCX is forecast to have no revenue next year.

Ricavi ad alta crescita: BCX is forecast to have no revenue next year.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Insufficient data to determine if BCX's Return on Equity is forecast to be high in 3 years time


Scoprire le aziende in crescita